HELIUS MEDICAL TECHNOLOGIE-A (HSDT) Stock Analyst Earnings Estimates
NASDAQ:HSDT - Nasdaq - US42328V8019 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 787K 51.35% | 644K -18.17% | 520K -19.25% | 381.48K -26.64% | 668.1K 75.13% | 42.421M 6,249.50% | 65.34M 54.03% | 78.07M 19.48% | 91.125M 16.72% | 97.676M 7.19% | |
| EBITDA YoY % growth | -14.504M 18.56% | -12.107M 16.53% | -13.803M -14.01% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -14.759M 18.55% | -12.269M 16.87% | -13.863M -12.99% | -14.558M -5.02% | -14.924M -2.51% | 23.711M 258.88% | 41.644M 75.63% | 55.307M 32.81% | 65.96M 19.26% | 71.064M 7.74% | |
| Operating Margin | -1,875.35% | -1,905.12% | -2,665.96% | -3,816.31% | -2,233.74% | 55.89% | 63.73% | 70.84% | 72.38% | 72.75% | |
| EPS YoY % growth | -1,740.00 63.46% | -216.90 87.53% | -835.65 -285.27% | -258.57 69.06% | -65.79 74.56% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -131.07 -1,265.31% | -51.51 -246.87% | -27.03 96.47% |
| Revenue Q2Q % growth | 76.5K -57.97% | 112.2K 120.00% | 142.8K -6.05% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.814M -16.63% | -3.418M 16.02% | -3.234M -4.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -382.50 -727.92% | -443.70 | 61.20 | 13.79% |
| Q4 2024 Q2Q % growth | -765.00 -3,369.39% | -719.10 | -45.90 | -6.38% |
| Q3 2024 Q2Q % growth | -14.85 81.97% | -16.22 | 1.37 | 8.44% |
| Q2 2024 Q2Q % growth | -9.60 78.67% | -7.65 | -1.95 | -25.49% |
| Q1 2024 Q2Q % growth | -46.20 31.56% | -59.21 | 13.01 | 21.97% |
| Q4 2023 Q2Q % growth | -22.05 82.71% | -57.73 | 35.68 | 61.81% |
| Q3 2023 Q2Q % growth | -82.35 -266.00% | -91.80 | 9.45 | 10.29% |
| Q2 2023 Q2Q % growth | -45.00 93.81% | -89.25 | 44.25 | 49.58% |
| Q1 2023 Q2Q % growth | -67.50 92.17% | -84.15 | 16.65 | 19.79% |
| Q4 2022 Q2Q % growth | -127.50 87.02% | -99.45 | -28.05 | -28.21% |
| Q3 2022 Q2Q % growth | -22.50 98.16% | -160.65 | 138.15 | 85.99% |
| Q2 2022 Q2Q % growth | -727.50 44.89% | -856.80 | 129.30 | 15.09% |
| Q1 2022 Q2Q % growth | -862.50 30.30% | -864.45 | 1.95 | 0.23% |
| Q4 2021 Q2Q % growth | -982.50 88.61% | -887.40 | -95.10 | -10.72% |
| Q3 2021 Q2Q % growth | -1,222.50 49.27% | -1,338.75 | 116.25 | 8.68% |
| Q2 2021 Q2Q % growth | -1,320.00 57.50% | -1,235.48 | -84.53 | -6.84% |
| Q1 2021 Q2Q % growth | -1,237.50 71.11% | -1,155.15 | -82.35 | -7.13% |
| Q4 2020 Q2Q % growth | -8,625.00 -56.37% | -1,354.05 | -7,270.95 | -536.98% |
| Q3 2020 Q2Q % growth | 58.27% | -2,409.75 | % | |
| Q2 2020 Q2Q % growth | -1,083.20% | -3,105.90 | % | |
| Q1 2020 Q2Q % growth | -426.40% | -4,284.00 | % | |
| Q3 2019 Q2Q % growth | -5,775.00 | -5,850.34 | 75.34 | 1.29% |
| Q2 2019 Q2Q % growth | -262.50 | -6,024.38 | 5,761.88 | 95.64% |
| Q1 2019 Q2Q % growth | 1,312.50 | -6,827.63 | 8,140.13 | 119.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 49K -63.70% | 102K | -53K | -51.96% |
| Q4 2024 Q2Q % growth | 152K 13.43% | 102K | 50K | 49.02% |
| Q3 2024 Q2Q % growth | 51K -64.34% | 153K | -102K | -66.67% |
| Q2 2024 Q2Q % growth | 182K -28.91% | 153K | 29K | 18.95% |
| Q1 2024 Q2Q % growth | 135K 21.62% | 133.11K | 1.89K | 1.42% |
| Q4 2023 Q2Q % growth | 134K -52.48% | 251.257K | -117.257K | -46.67% |
| Q3 2023 Q2Q % growth | 143K -28.50% | 351.9K | -208.9K | -59.36% |
| Q2 2023 Q2Q % growth | 256K 113.33% | 192.097K | 63.903K | 33.27% |
| Q1 2023 Q2Q % growth | 111K -41.58% | 288.997K | -177.997K | -61.59% |
| Q4 2022 Q2Q % growth | 282K 8.46% | 264.18K | 17.82K | 6.75% |
| Q3 2022 Q2Q % growth | 200K 81.82% | 170.85K | 29.15K | 17.06% |
| Q2 2022 Q2Q % growth | 120K 71.43% | 367.2K | -247.2K | -67.32% |
| Q1 2022 Q2Q % growth | 190K 137.50% | 163.2K | 26.8K | 16.42% |
| Q4 2021 Q2Q % growth | 260K 36.84% | 102K | 158K | 154.90% |
| Q3 2021 Q2Q % growth | 110K -15.38% | 86.19K | 23.81K | 27.63% |
| Q2 2021 Q2Q % growth | 70K -46.15% | 96.9K | -26.9K | -27.76% |
| Q1 2021 Q2Q % growth | 80K -61.90% | 85.17K | -5.17K | -6.07% |
| Q4 2020 Q2Q % growth | 190K 26.67% | 193.8K | -3.8K | -1.96% |
| Q3 2020 Q2Q % growth | 130K -13.33% | 101.499K | 28.501K | 28.08% |
| Q2 2020 Q2Q % growth | 130K -75.00% | 101.499K | 28.501K | 28.08% |
| Q1 2020 Q2Q % growth | 210K -69.12% | 304.499K | -94.499K | -31.03% |
| Q3 2019 Q2Q % growth | 150K | 306K | -156K | -50.98% |
| Q2 2019 Q2Q % growth | 520K | 306K | 214K | 69.93% |
| Q1 2019 Q2Q % growth | 680K | 153K | 527K | 344.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4939.22% | 0% | -2540.62% |
| Revenue | 0% | -31.82% | 0% | -26.67% |